Dysfunctional Interaction of C/EBPα and the Glucocorticoid Receptor in Asthmatic Bronchial Smooth-Muscle Cells

Normally, the growth of airway smooth-muscle cells is kept in check by the antiproliferative effects of glucocorticoids acting in concert with the glucocorticoid receptor and CCAAT/enhancer binding protein α (C/EBPα). These investigators show that airway smooth muscle from patients with asthma has a...

Full description

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 351; no. 6; pp. 560 - 574
Main Authors Roth, Michael, Johnson, Peter R.A, Borger, Peter, Bihl, Michel P, Rüdiger, Jochen J, King, Gregory G, Ge, Qi, Hostettler, Katrin, Burgess, Janette K, Black, Judith L, Tamm, Michael
Format Journal Article
LanguageEnglish
Published Boston, MA Massachusetts Medical Society 05.08.2004
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Normally, the growth of airway smooth-muscle cells is kept in check by the antiproliferative effects of glucocorticoids acting in concert with the glucocorticoid receptor and CCAAT/enhancer binding protein α (C/EBPα). These investigators show that airway smooth muscle from patients with asthma has a selective deficiency of C/EBPα, thus obviating the antiproliferative effects of glucocorticoids. A selective deficiency of CCAAT/ enhancer binding protein α in airway smooth muscle from patients with asthma. Asthma is characterized pathologically by an increased mass of bronchial smooth muscle, 1 , 2 apparently as a result of the enhanced proliferation of bronchial smooth-muscle cells. 3 , 4 Bronchial smooth-muscle cells are thus considered a major target for antiasthma treatments such as glucocorticoids. 5 Glucocorticoids down-regulate the secretion of several inflammatory cytokines by various types of cells resident in the human lung, 6 – 9 and this process is thought to be mediated by the ligand-activated glucocorticoid receptor. 9 – 11 On activation, the glucocorticoid receptor migrates to the nucleus, where it binds to its specific DNA consensus sequence, the glucocorticoid-responsive element, 9 – 11 or interacts with other . . .
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa021660